Company / Operating Income per Share
10x Genomics, Inc. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.50
FY2025
5-year range
-$4.75 / -$0.28
FY2021-FY2025
Trend
+69.5%
vs FY2024
Sector context
#115 of 154
Health Care
What the data says
10x Genomics, Inc.'s operating income per share of $-0.50 is lower than 75% of companies in the Health Care sector (FY2025). Operating Income per Share has increased for 3 consecutive years, from $-4.75 in FY2022 to $-0.50 in FY2025.
Based on SEC 10-K filings.
-0.50 in FY2025.
Improved from $-2.30 to $-0.50 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 154This company -$0.50 Sector average $4.25
▼
-111.7% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 69.5% year-over-year.
- Ranks #115 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.50 | +69.5% |
| FY2024 | -$1.63 | +29.1% |
| FY2023 | -$2.30 | +51.5% |
| FY2022 | -$4.75 | -1584.5% |
| FY2021 | -$0.28 | +94.9% |
| FY2020 | -$5.55 | -164.1% |
| FY2019 | -$2.10 | +74.6% |
| FY2018 | -$8.27 | -421.6% |
| FY2017 | -$1.59 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026